Skip to main content
David Sullivan, MD, Anesthesiology, New York, NY

David CharlesAnthony Sullivan MD MPH


Physician

Join to View Full Profile
  • 1 Gustave L Levy PlNew York, NY 10029

  • Phone+1 212-241-6426

  • Fax+1 212-876-3906

Dr. Sullivan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • David Sullivan, MD, is an anesthesiologist based in New York, NY. He completed his residency in anesthesiology at the Icahn School of Medicine at Mount Sinai. He graduated with an MD in 2018 from Geisinger Commonwealth School of Medicine, following a BS in Biochemistry and an MPH in Health Care Administration and Policy from Case Western Reserve University. Since 2022, he has been serving as an Assistant Professor at The Mount Sinai Hospital. Dr. Sullivan has published research on clinical outcomes and treatment impacts in patients with hepatocellular carcinoma, with his work featured in the Journal of Clinical Oncology.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Anesthesiology, 2018 - 2022
  • Commonwealth Medical College
    Commonwealth Medical CollegeClass of 2018, MD
  • Case Western Reserve University
    Case Western Reserve UniversityMPH, Health Care Administration and Policy, 2012 - 2014
  • Case Western Reserve University
    Case Western Reserve UniversityBS, Biochemistry, 2008 - 2012

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2022 - 2027
  • Anesthesiology
    American Board of Anesthesiology Anesthesiology

Publications & Presentations

Abstracts/Posters

  • Diverse clinical outcome and predictors for clinical outcome in patients with HCC treated with TACE.
    Prarthna Bhardwaj, Petra Prins, Alexander Y. Kim, Rheena Jha, Hongkun Wang, David Sullivan, Salha Taher, Tiger Zhang, J Zhu, John Marshall, Aiwu Ruth He, Journal of Clinical Oncology, 2016 34:4_suppl, 442-442, 2/1/2016
  • The impact of the multiple types of treatments on OS and the decline of liver function in patients with advanced stage of HCC.
    Petra Prins, Prarthna Bhardwaj, Thomas Fishbein, Lynt B. Johnson, Coleman Smith, Rohits Satoskar, Alexander Y. Kim, Reena Jha, Hongkun Wang, David Sullivan, Salha Tahe..., Journal of Clinical Oncology, 2016 34:4_suppl, 461-461, 2/1/2016

Press Mentions

  • Early Use of Convalescent Plasma Reduced Hospitalizations, Raising Hopes for Treating Omicron Variant, Scientists Say
    Early Use of Convalescent Plasma Reduced Hospitalizations, Raising Hopes for Treating Omicron Variant, Scientists SayDecember 21st, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: